Home/Filings/4/0001493152-25-025203
4//SEC Filing

Singhvi Rahul 4

Accession 0001493152-25-025203

CIK 0001962011other

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 5:26 PM ET

Size

4.9 KB

Accession

0001493152-25-025203

Insider Transaction Report

Form 4
Period: 2025-10-08
Transactions
  • Award

    COMMON STOCK

    2025-10-08+19,08449,204 total
Footnotes (2)
  • [F1]Represents 19,084 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 19,084 RSUs are scheduled to vest in full on the first anniversary of the grant date.
  • [F2]Consists of 49,204 RSUs which remain subject to vesting.

Documents

1 file

Issuer

Kairos Pharma, LTD.

CIK 0001962011

Entity typeother

Related Parties

1
  • filerCIK 0001322731

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 5:26 PM ET
Size
4.9 KB